Potential Analysis of Human DNA Vaccines Market: Recent Industry Developments And Growth Strategies Adopted By Players
The Global Potential Analysis Of Human DNA Vaccines Market is expected to account for $3,762 million by 2020 and reach $9,337 million by 2030, growing at a CAGR of 9.5% from 2020 to 2030. Key opportunities for market expansion include the high need for vaccines for immunization & prevention of infectious diseases.
Vaccines used currently are composed of killed pathogen or live attenuated viruses, whereas DNA vaccines consist of the DNA sequence of the antigen, which is administered in humans to stimulate an immune response. This approach offers a number of potential advantages over traditional approaches, including the stimulation of both B- and T-cell responses, improved vaccine stability, the absence of any infectious agent, and the relative ease of large-scale manufacture.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/2309
The major Key players Are:
- Inovio Pharmaceuticals, Inc.
- GeneOne Life Science Inc.
- Immunomic Therapeutics, Inc.
- Astellas Pharma, Inc.
- Pharos Biologicals
- Sanofi S.A.
- F. Hoffmann-La Roche AG
- Boehringer Ingelheim GmbH.
In addition, DNA vaccines are temperature stable, leading to easier storage and transport. DNA vaccination may provide an important tool for stimulating an immune response in HBV, HCV, and HIV patients, owing to their therapeutic potential for ongoing chronic viral infection. For instance, Inovios INO-3112 is in phase II clinical trial, and can be used to treat cervical cancer caused by HPV. This immunotherapy enables the body to produce E6 and E7 antigens to induce a stronger targeted immune response against HPV-associated diseases, such as cervical cancer.
Get a purchase Enquiry @ https://www.alliedmarketresearch.com/purchase-enquiry/2309
Key Findings of the Potential Analysis of Human DNA Vaccines Market:
- North America is expected to dominate the market in 2020, and is projected to grow at the highest CAGR during the forecast period.
- Europe is the second largest potential market, and is expected to grow at a CAGR of 9.0%.
Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
This post was originally published on Pharmaceutical Industry